ROCHE HOLDING AG

Press Releases Roche Holding AG

Equities

ROP

CH1499059983

Pharmaceuticals

End-of-day quote Swiss Exchange Other stock markets 2026-06-05			5-day change	1st Jan Change
327.10 ^CHF	+0.77%		-0.67%	-0.34%

Jun. 05	Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial	RE
Jun. 05	Zealand touts promising tolerability data for obesity drug in mid-stage study	RE

Press Releases

Jun. 04	Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection	PR
Jun. 02	FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting	BU
Jun. 01	Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions	BU
May. 19	Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer	BU
May. 15	FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment	BU
Apr. 30	Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026	BU
Apr. 24	Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign	BU
Apr. 22	Roche's ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD	AQ
Apr. 21	Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS	BU
Apr. 21	Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD	BU
Apr. 21	CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Roche Holding: An assuring start to the year

Roche Holding: An assuring start to the year

April 23, 2026 at 09:32 am EDT

The Price of Patience

April 23, 2026 at 05:17 am EDT

The Price of Patience

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!